"This is the most promising near term biotech on the asx. We even have revenue! Unheard of."
Not promoting any stock here, but Orthocell has equivent revenue with a lower Mcap, more cash on hand and newely signed distribution deals ready to go to market. Everyone thinks their stock will be the GOAT.
PIQ Price at posting:
$1.17 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)